FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943742802> ?p ?o ?g. }

• W2943742802 endingPage "e2019026" @default.
• W2943742802 startingPage "e2019026" @default.
• W2943742802 abstract "β-thalassemia intermedia (TI) spans a wide spectrum of severity and carries higher morbidity than previously recognized, including extramedullary hematopoiesis, leg ulcers, gallstones, thrombosis, secondary heart failure, pulmonary hypertension, skeletal deformity, growth retardation and endocrine abnormalities, such as diabetes mellitus, hypothyroidism, osteoporosis, and hypogonadism.To evaluate the final height and the endocrine complications encountered in young adult patients with TI followed at Hematology Section, Doha (Qatar) in relation to liver iron content in non-transfused versus infrequently transfused TI patients.This retrospective cohort study was performed on 28 young adults with TI who were randomly selected from the Hematology Clinic of the Hematology Section, National Centre for Cancer Care and Research, Hamad Medical Corporation of Doha (Qatar).Eligibility criteria for this retrospective analysis included TI patients diagnosed by complete blood count, hemoglobin electrophoresis and young adult age ( ≥ 18 years).Group 1 included nine patients who did not receive any blood transfusion, and Group 2 included 19 patients who infrequently received blood transfusions.Data recorded from charts included demographic characteristics (gender, date of birth, ethnicity), disease and treatment characteristics (e.g., transfusion frequency, history of chelation therapy, and splenectomy), auxological and pubertal data [growth percentiles and pubertal stages, and body mass index (BMI)], laboratory data and target organ complications (including endocrinopathies and liver disease). Iron overload was assessed by direct (liver iron content; LIC) and indirect methods (SF), and bone mass index (BMA) by dual-energy X-ray absorptiometry (DXA).Short stature [Final Height (Ht) SDS < -2] occurred in 25% of patients with no difference between the two groups of patients. Insulin growth factor 1 (IGF-1) SDS was low in 35.7 % of patients with no statistical difference among the two groups. Impaired fasting blood glucose occurred in 17.8% of patients, diabetes mellitus in 25% and hypogonadotropic hypogonadism in 10.7% of them. Morning cortisol was low in one patient. No thyroid or hypo-parathyroid abnormalities were detected in any patient. Liver iron content (LIC) > 15 mg/g dry weight and SF > 2,000 ng/mL were detected in 75% of the patients. The values resulted significantly higher in the transfused group (Group 2). High liver enzyme level (ALT) was detected in 42.8 % of patients, and the values were significantly higher in the transfused group (Group 2). Total and fetal Hb was significantly higher in group 1 versus group 2. Osteopenia was diagnosed in 14.3% of patients. Females had significantly better final height SDS, higher IGF-1 SDS, lower LIC and fasting blood glucose level compared to males. Significant correlations were found between Ht-SDS and IGF-1 SDS; LIC and SF, level; ALT and LIC, SF levels. Total and fetal Hb did not correlate significantly with Ht-SDS or IGF-1 level.A significant number of TI patients have high LIC, short stature and endocrine disorders. Patients who require occasional transfusions have more liver iron overload and higher hepatic dysfunction. Females appear to attain a better final adult height and have higher IGF1-SDS versus males. Our data emphasize the need for long term surveillance for identification of organ-specific risk factors and early disease manifestations. We also recommend close monitoring of endocrine and other complications, according to the international guidelines." @default.
• W2943742802 created "2019-05-09" @default.
• W2943742802 creator A5003933274 @default.
• W2943742802 creator A5011250578 @default.
• W2943742802 creator A5013333198 @default.
• W2943742802 creator A5017891302 @default.
• W2943742802 creator A5041514548 @default.
• W2943742802 date "2019-04-25" @default.
• W2943742802 modified "2023-10-13" @default.
• W2943742802 title "FINAL HEIGHT AND ENDORINE COMPLICATIONS IN PATIENTS WITH β-THALASSSEMIA INTERMEDIA: OUR EXPERIENCE IN NON-TRANSFUSED VERSUS INFREQUENTLY TRANSFUSED PATIENTS AND CORRELATIONS WITH LIVER IRON CONTENT" @default.
• W2943742802 cites W104156556 @default.
• W2943742802 cites W1575413653 @default.
• W2943742802 cites W1924064069 @default.
• W2943742802 cites W1967676619 @default.
• W2943742802 cites W1984997586 @default.
• W2943742802 cites W1988185165 @default.
• W2943742802 cites W1992773264 @default.
• W2943742802 cites W1995135594 @default.
• W2943742802 cites W2002791371 @default.
• W2943742802 cites W2027404967 @default.
• W2943742802 cites W2040565216 @default.
• W2943742802 cites W2040990148 @default.
• W2943742802 cites W2048103562 @default.
• W2943742802 cites W2052473168 @default.
• W2943742802 cites W2064631448 @default.
• W2943742802 cites W2069879542 @default.
• W2943742802 cites W2072490749 @default.
• W2943742802 cites W2072964937 @default.
• W2943742802 cites W2082074329 @default.
• W2943742802 cites W2083441049 @default.
• W2943742802 cites W2097297670 @default.
• W2943742802 cites W2109769448 @default.
• W2943742802 cites W2114486527 @default.
• W2943742802 cites W2116301773 @default.
• W2943742802 cites W2120053954 @default.
• W2943742802 cites W2120753754 @default.
• W2943742802 cites W2128995476 @default.
• W2943742802 cites W2130794855 @default.
• W2943742802 cites W2142095300 @default.
• W2943742802 cites W2154025803 @default.
• W2943742802 cites W2166782145 @default.
• W2943742802 cites W2169830687 @default.
• W2943742802 cites W2230895271 @default.
• W2943742802 cites W2402714597 @default.
• W2943742802 cites W2411756507 @default.
• W2943742802 cites W2520830415 @default.
• W2943742802 cites W2570687557 @default.
• W2943742802 cites W2589779391 @default.
• W2943742802 cites W2615856857 @default.
• W2943742802 cites W2784611469 @default.
• W2943742802 cites W2898226442 @default.
• W2943742802 cites W2898485010 @default.
• W2943742802 cites W3015459527 @default.
• W2943742802 cites W1992439969 @default.
• W2943742802 cites W72199872 @default.
• W2943742802 doi "https://doi.org/10.4084/mjhid.2019.026" @default.
• W2943742802 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6548215" @default.
• W2943742802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31205630" @default.
• W2943742802 hasPublicationYear "2019" @default.
• W2943742802 type Work @default.
• W2943742802 sameAs 2943742802 @default.
• W2943742802 citedByCount "11" @default.
• W2943742802 countsByYear W29437428022020 @default.
• W2943742802 countsByYear W29437428022021 @default.
• W2943742802 countsByYear W29437428022022 @default.
• W2943742802 countsByYear W29437428022023 @default.
• W2943742802 crossrefType "journal-article" @default.
• W2943742802 hasAuthorship W2943742802A5003933274 @default.
• W2943742802 hasAuthorship W2943742802A5011250578 @default.
• W2943742802 hasAuthorship W2943742802A5013333198 @default.
• W2943742802 hasAuthorship W2943742802A5017891302 @default.
• W2943742802 hasAuthorship W2943742802A5041514548 @default.
• W2943742802 hasBestOaLocation W29437428021 @default.
• W2943742802 hasConcept C126322002 @default.
• W2943742802 hasConcept C141071460 @default.
• W2943742802 hasConcept C167135981 @default.
• W2943742802 hasConcept C187212893 @default.
• W2943742802 hasConcept C2776309230 @default.
• W2943742802 hasConcept C2776455275 @default.
• W2943742802 hasConcept C2777799968 @default.
• W2943742802 hasConcept C2778063713 @default.
• W2943742802 hasConcept C2780014101 @default.
• W2943742802 hasConcept C2780221984 @default.
• W2943742802 hasConcept C2780931953 @default.
• W2943742802 hasConcept C71924100 @default.
• W2943742802 hasConceptScore W2943742802C126322002 @default.
• W2943742802 hasConceptScore W2943742802C141071460 @default.
• W2943742802 hasConceptScore W2943742802C167135981 @default.
• W2943742802 hasConceptScore W2943742802C187212893 @default.
• W2943742802 hasConceptScore W2943742802C2776309230 @default.
• W2943742802 hasConceptScore W2943742802C2776455275 @default.
• W2943742802 hasConceptScore W2943742802C2777799968 @default.
• W2943742802 hasConceptScore W2943742802C2778063713 @default.
• W2943742802 hasConceptScore W2943742802C2780014101 @default.
• W2943742802 hasConceptScore W2943742802C2780221984 @default.
• W2943742802 hasConceptScore W2943742802C2780931953 @default.
• W2943742802 hasConceptScore W2943742802C71924100 @default.
• W2943742802 hasIssue "1" @default.

• next